Nu Skin Enterprises, Inc.
NUS
$8.48
-$0.09-1.05%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.68% | -5.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.68% | -5.68% | |||
| Cost of Revenue | 0.79% | -10.73% | |||
| Gross Profit | 2.05% | -3.39% | |||
| SG&A Expenses | 1.56% | 0.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.32% | -3.60% | |||
| Operating Income | 7.40% | -29.69% | |||
| Income Before Tax | 13.74% | -41.65% | |||
| Income Tax Expenses | 441.01% | -117.24% | |||
| Earnings from Continuing Operations | -15.15% | -19.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.15% | -19.13% | |||
| EBIT | 7.40% | -29.69% | |||
| EBITDA | 7.18% | -23.04% | |||
| EPS Basic | -13.71% | -19.08% | |||
| Normalized Basic EPS | -122.81% | -20.50% | |||
| EPS Diluted | -17.53% | -20.41% | |||
| Normalized Diluted EPS | -122.61% | -21.85% | |||
| Average Basic Shares Outstanding | -1.65% | -0.09% | |||
| Average Diluted Shares Outstanding | -0.79% | 1.64% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.16% | 0.24% | |||